You went in because something felt off. Energy gone by 2pm. Libido somewhere in the basement. Training hard and going backward. Mood flat in a way that isn’t quite sadness.
They drew blood. The call came back: everything’s normal.
And you’re standing there holding a piece of paper that says you’re fine while feeling like you’re not.
Here’s what actually happened in that exchange, because it isn’t what most people think, and it isn’t what most clinics selling you the alternative want you to think either.
The reference range on a lab report exists to answer one question: does this person have a disease?
That’s it. That’s the job. It’s a screening tool designed to separate pathology from non-pathology, and at that job it works reasonably well.
The question you walked in with was different. You asked, in effect: is my physiology optimal for how I want to function? The lab report has no opinion on that, because it wasn’t built to have one.
When a physician says “your testosterone is normal,” the accurate translation is “your testosterone is not low enough to constitute a diagnosable deficiency by the criteria I’m working from.” That’s a true statement. It’s just not an answer to your question.
This is not incompetence, and any clinic that tells you it is should worry you. A primary care visit is built to catch disease in a limited window with limited information. It’s a triage instrument. Ruling out pathology is what it’s for, and it does that well — which is why you want it doing exactly that when something serious is actually happening.
The gap isn’t a failure of skill. It’s a difference in scope. And understanding that distinction is more useful than being angry about it.
This part is genuinely worth knowing, because once you understand the construction, the whole thing makes more sense.
A reference range is derived from a population. You take a sample of men, measure their testosterone, and define “normal” as roughly the middle 95% of that distribution — typically the 2.5th to 97.5th percentile.
Notice what that method does and doesn’t do. It describes what’s common. It says nothing about what’s healthy, optimal, or desirable. It’s a statement about distribution, not about function.
Two consequences follow, and they’re both significant.
First: the range includes the bottom of the distribution by construction. Somebody has to be at the 5th percentile. That’s arithmetic. Being in the range tells you that you’re not an outlier — it does not tell you that you’re where you want to be.
Second, and more interesting: if the underlying population’s testosterone is declining, the reference range built from that population drifts down with it. And the population’s testosterone is declining — multiple independent datasets document an age-independent secular decline averaging roughly 1% per year. Among tested patients, the proportion with low levels rose from 35% in 2002 to 47.3% in 2011.
A range calibrated against a declining population normalizes the decline. That’s not a conspiracy — it’s what the method does by design. But it means “normal” is a moving target defined by your peers, and your peers are trending in a direction nobody’s happy about.
Most standard panels report total testosterone. That’s the number that came back normal.
Total testosterone measures everything in circulation — but the large majority of it is bound to sex hormone-binding globulin and albumin, and bound testosterone isn’t biologically available to your tissues. Free testosterone is the fraction that’s actually doing anything.
SHBG rises with age. So two men with identical total testosterone can have meaningfully different free testosterone depending on their SHBG — and the man with high SHBG is functionally lower despite an identical number on the report. Notably, in the large longitudinal data documenting the population decline, an increase in SHBG remained significant.
If your total came back normal and nobody measured free testosterone or SHBG, you have one number where you needed three. That’s not a fringe complaint — it’s a standard part of a proper workup.
Then there’s timing. Testosterone follows a diurnal rhythm, peaking in the morning. A single draw at 3pm on a day after bad sleep is a snapshot at the trough of a curve, and it’s being compared to a range built largely from morning draws. It’s not a wrong number. It’s an unrepresentative one, and one draw is a data point, not a trend.
Now the uncomfortable half, and the reason to be suspicious of anyone who only tells you the first half.
Everything above is a real limitation of standard testing, and it’s also the exact argument used to sell testosterone to men who don’t need it. The “your doctor is wrong, your labs are meaningless, come to us” pitch is built on legitimate criticism deployed dishonestly.
So hold both:
Your symptoms might not be hormonal. Fatigue, low libido, poor recovery, and flat mood are the symptom picture for low testosterone, and also for sleep apnea, chronic sleep debt, thyroid dysfunction, iron deficiency, depression, and being 44 with two kids and a demanding job. A meaningful number of men convinced they have low T turn out to have something else — often something more fixable.
A normal number can be the right answer. Sometimes “your testosterone is fine” is accurate and the problem is elsewhere, and finding out is more valuable than a prescription that treats the wrong thing.
Optimization has limits too. There’s no established evidence that pushing a normal man toward the top of the range produces the outcomes people are imagining. “Optimal” is a real concept and also a marketing word, and it’s used both ways.
The FDA’s own framing is worth noting: when it removed the cardiovascular boxed warning from testosterone products in February 2025 based on the TRAVERSE trial, it retained the Limitation of Use language for age-related hypogonadism, and added a new warning about blood pressure increases. TRAVERSE’s own lead investigator cautioned against overinterpreting it — the trial enrolled men with documented hypogonadism, defined as two testosterone levels under 300 ng/dL on separate days plus symptoms. Men obtaining testosterone outside those parameters weren’t what the trial studied.
That’s the honest picture. Better than the 2014-era fear. Not a blank check.
Most of the debate lands on a single threshold: 300 ng/dL. Below it, you have a diagnosis. Above it, you’re normal.
Worth knowing that this cutoff carries less authority than its use implies. Different professional societies have proposed different thresholds. Different labs report different ranges depending on the population they sampled and the assay they use. The same blood, sent to two labs, can come back flagged at one and unflagged at the other.
That variability isn’t a scandal — it’s what happens when you draw a line through a continuous distribution. Biology doesn’t have a cliff at 300. A man at 295 and a man at 305 are not meaningfully different people, and yet one gets a diagnosis and one gets “you’re fine.”
The threshold exists because clinical decisions require lines. TRAVERSE, the trial that drove the FDA’s 2025 labeling change, defined hypogonadism as two testosterone levels under 300 ng/dL on separate days plus associated symptoms — note that both the number and the symptoms were required, and that two draws were required rather than one.
That’s a reasonable operational definition for a trial. It’s also a reminder that the number alone was never meant to carry the whole decision.
The word does real work and gets abused, so it’s worth pinning down.
The legitimate version: a man at the 15th percentile of a declining population range, with symptoms, whose free testosterone is further suppressed by high SHBG, may function meaningfully better higher in the range even though he never crossed a diagnostic threshold. That’s a defensible clinical judgment, made by a physician, with labs and symptoms and a treatment goal.
The abused version: “optimal” as a permission structure for treating anyone who wants treatment, where the target is whatever the patient hoped for and the evidence base is a testimonial.
The distinction isn’t the word. It’s whether there’s a measurable goal, a defined endpoint, monitoring, and a willingness to conclude the intervention isn’t working.
It’s also worth being honest that the evidence thins as you move up the range. The data supporting treatment of genuine deficiency is reasonably good. The data supporting pushing a mid-range man toward the top is much weaker — largely absent, in fact, for the outcomes people are usually chasing. That doesn’t make it wrong in every case. It does mean anyone promising you specific results in that territory is extrapolating.
And the lab-guided approach exists precisely to keep the word honest: measure, treat toward a defined target when indicated, remeasure, and stop when it isn’t working.
If “normal” didn’t resolve it, the path forward isn’t finding someone who’ll ignore the number. It’s getting a picture complete enough to actually interpret.
That means total and free testosterone, with SHBG, so you know what’s bioavailable rather than what’s circulating. Morning draws, ideally more than one, since a single measurement can’t distinguish a low day from a low pattern. LH and FSH, which tell you whether a low signal is coming from the testes or from upstream — a distinction that changes the treatment entirely. Estradiol, since the ratio matters and aromatization is part of the picture. And the rest of the differential: thyroid, ferritin, vitamin D, metabolic panel — the things that produce identical symptoms and get missed when everyone’s looking at one hormone.
Then someone has to sit with all of it alongside your actual symptoms and your actual life, and form a judgment. That’s the part a 12-minute visit structurally can’t do, and it’s not a knock on the visit — it’s a description of what different appointments are for.
If your testosterone is genuinely low and symptomatic, that’s worth addressing, and there are real options.
If it’s borderline and your sleep is a disaster, fix the sleep first. It’s free, the mechanism is well characterized, and it may move your number 10-30% on its own — which is a meaningful change, and one that doesn’t commit you to anything.
If it’s fine and you feel terrible, something else is going on, and finding it is the whole point.
And if you came here hoping we’d tell you your doctor was an idiot and you need testosterone — we might tell you the opposite. That’s the version of this that’s actually worth your time.
Want the full picture instead of one number?
Book a free 15-minute consult at Optimal Wellness St. Pete. We’ll go through your symptoms, order the panel that would actually answer the question, and give you a straight read — including if the answer is that your hormones aren’t the problem.
Book your free 15-minute consult →
Or call 727-201-9095. We’re at 1640 Central Ave, St. Petersburg.
This article is educational and is not medical advice. It is not intended to contradict or replace guidance from your physician. Individual results vary. Hormone evaluation and any resulting treatment require assessment by a licensed provider. Testosterone products are FDA-approved for men with conditions associated with a deficiency or absence of endogenous testosterone; labeling retains a Limitation of Use for age-related hypogonadism.
